RC(SZ:300596) Zheng Quan Ri Bao·2026-01-08 16:45Core Insights - The company emphasizes strategic stability during adversity, focusing on its core chemical business while also investing in biotechnology as a new growth engine [1] Group 1: Business Strategy - The company is a leader in the polymer materials anti-aging industry and has experienced rapid growth since its listing on the Shenzhen Stock Exchange in 2017 [2] - The company identifies three global trends: supply chain restructuring, energy transition, and the omnipresence of AI, which will guide its R&D and investment strategies [2] - The company is committed to technological innovation to upgrade its business, expanding from material anti-aging to human anti-aging products, with nine categories of traditional chemical sunscreen products already launched [2][3] Group 2: International Expansion - The company is actively pursuing international expansion, as evidenced by its recent announcement of capital increases to support the construction of a research and production base in Malaysia [2] - The company aims to establish a robust supply chain to support emerging industries such as new energy vehicles and flexible displays through acquisitions and new production bases [3] Group 3: Biotechnology Development - The company views biotechnology as a strategic new engine for growth, focusing on life sciences to create long-term value [3] - The company has invested in R&D for small nucleic acid drugs, biomanufacturing, and personal care, collaborating with institutions like Tianjin University [3] Group 4: Operational Efficiency - The company has implemented a ten-year strategic planning management model to ensure effective execution of its strategies [4] - The management team has maintained a zero voluntary turnover rate, indicating strong organizational cohesion [4] - The company has outlined three key areas for capital expenditure: differentiated domestic investments, a focus on biological innovation, and increased international presence [4]